Johnson & Johnson, Imerys must pay $117 million to New Jersey man in asbestos cancer case

NEW YORK (Reuters) – Johnson & Johnson and a unit of Imerys SA must pay $117 million in damages to a man who said he developed cancer due to his exposure to asbestos in talc-based products, a New Jersey state court jury said on Wednesday.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply